Top Stories

FDA approves first generic Naloxone nasal spray to reverse opioid overdoses

WASHINGTON, DC - OCTOBER 25: Dr. Nora Volkow, director at the National Institute on Drug Abuse (NIDA) and National Institutes of Health (NIH), holds up a narcan nasal spray (naloxone) (Photo by Drew Angerer/Getty Images)